Oncimmune
Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories
De Soto, KS (PRWEB) November 07, 2011
Oncimmune (USA) LLC, maker of EarlyCDT®-Lung, a simple blood test that aids physicians in the early detection of lung cancer, is promoting Lung Cancer Awareness Month (LCAM) through an educational blog series. The series will feature 30 stories in 60 days from lung cancer survivors, those currently battling the disease and people who have lost loved ones to lung cancer.
Founded in 2006, Oncimmune (USA) LLC is committed to the ongoing pursuit of early cancer detection methods. Now offering the EarlyCDT-Lung test in all 50 states, Oncimmune is changing the way physicians approach lung cancer detection. EarlyCDT-Lung is a simple blood test used to identify specific autoantibodes (immuno-biomarkers), which are elevated in patients with lung cancer. Because these autoantibodies are present at the earliest stages of the disease, EarlyCDT-Lung can be used to aid in diagnosing high risk patients, potentially before they exhibit specific symptoms of lung cancer.
Observed during the month of November, LCAM is an annual educational campaign designed to raise awareness about the risk factors of lung cancer, detection methods, symptoms and available treatment options. During this annual observation, thought leaders in lung cancer research and education work together to foster conversation about this dangerous disease.
Oncimmune is doing their part to raise awareness during LCAM. The blog series was launched on Oncimmune’s educational website, http://www.HelloHaveYouHeard.com, on October 25. The 30 Stories in 60 Days series will run through mid-December. Each week the blog will feature stories of lung cancer survivors, as well as accounts from those who have lost loved ones to the disease.
One such story is of Sandra, a 66 year old lung cancer survivor. Sandra was a heavy smoker, but had stopped smoking in 2003. After suffering a continuous pain in her side, Sandra had a CT scan. The CT revealed a spot on her left lung. Her doctor recommended remaining vigilant with frequent follow-up imaging. While the spot on her lung was visible by CT, a PET scan did not reveal any signs of it being cancer.
Having lost her brother to the disease, this scare motivated Sandra to do more research. During her investigation she discovered Oncimmune’s Facebook page, and learned about EarlyCDT-Lung. Sandra decided to order an EarlyCDT-Lung collection kit and worked with her pulmonologist to have her blood drawn. The test results were positive, indicating that lung cancer might be present. After further evaluation, it turned out that Sandra had stage IA adenocarcinoma, predominantly bronchioloalveolar type.
Fortunately, her cancer had not spread to her lymph nodes and a thoracic surgeon was able to remove the tumor. In fact, just a couple weeks after Sandra’s surgery, she was back to teaching Zumba classes.
“We are honored to share these inspirational stories from some very strong individuals,” said Dan Calvo, President and CEO of Oncimmune. “Lung cancer has impacted my immediate family and I know that raising awareness about lung cancer through sharing of personal experiences is a valuable tool to fight and cope with this disease.”
In addition to the 30 Stories in 60 Days campaign, Oncimmune released an educational video series to promote LCAM. Each video provides insight and information to help the general public better understand the risks factors of lung cancer and the importance of early detection. Watch for more exciting announcements from Oncimmune as they work to educate the public about lung cancer during LCAM and throughout the year.
About Oncimmune LLC
Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. The company is committed to advancing early cancer detection through proprietary immuno-biomarker technologies based on biological technology identified by John Robertson, M.D., Professor of Surgery at Nottingham University, England, and Chief Scientific Officer of Oncimmune LTD. Ongoing research and development is conducted by Oncimmune under the direction of Professor Robertson. The company’s mission is to develop early cancer detection tests to identify more than 90% of solid-tumor cancers, which make up 70% of all cancers including lung, breast, colorectal, prostate, stomach, pancreatic and ovarian. All testing is performed exclusively at Oncimmune’s CLIA (Clinical Laboratory Improvement Act) regulated laboratory located in the metro Kansas City area. Oncimmune (USA) LLC is a wholly owned subsidiary of Oncimmune LTD. Oncimmune LTD owns a portfolio of patents, including Patent Nos. 7,402,403 and 7,205,117, with five others currently filed and under review. For more information about Oncimmune, visit: http://www.hellohaveyouheard.com.
###
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Psoriasin Multi-Symptom Psoriasis Relief Ointment, Intensive Moisturizing, 4 Ounces (Pack of 2)Topical Ointment. Stop psoriasis suffering. Doctor recommended. Stops itching & flaking. Eliminates redness & scaling. Helps preve…
Cancer: Symptoms & Treatment History (1940s) [DVD]Cancer is an interesting short film that explains the signs and symptoms of cancer and its treatment. It features Mr. Bert Marshal…
Categories: Cancer Symptoms Tags: , Awareness, Cancer, Featuring, Individual, Lung, month, Recognizes, Stories
Annual Screening Chest X-Ray Does Not Reduce Lung Cancer Deaths
Annual screening for lung cancer using a standard chest x-ray does not reduce the risk of dying from lung cancer when compared with no annual screening, according to findings from the NCI-led Prostate, Lung, Colorectal, and Ovarian (PLCO) screening trial. The results from a median of nearly 12 years of follow-up were published online October 26 in JAMA.
NCI Cancer Bulletin
Cancer Cause Powerpoint Template – Cancer Cause Powerpoint slidesInteractive Cancer Cause PowerPoint templates are available for PowerPoint presentations. The Cancer Cause ppt templates are ama…
Specially designed for generous beauity junkies, this limited time offer features three tube of the #1 Hair Recontructor in the Wo…
Walk For The Cause Doll In Support Of Breast Cancer Awareness by Ashton DrakeBreast Cancer Awareness Doll! Exclusive First Ball-Jointed Doll Created to Help Find a Cure by Doll Artist Dianna Effner! – Breast…
Stage 4 bone and lung cancer survival rate?
Question by Carly: Stage 4 bone and lung cancer survival rate?
My friends father was just diagnosed with stage four bone and lung cancer. Does anyone know the survival rate. I know it is very short.
Best answer:
Answer by gazeygoo
Zero
Know better? Leave your own answer in the comments!
2011-2012 Pink Ribbon Pocket Planners – Set of 3This set includes 3 planners: 1 Strength Faith Love Survival, 1 Strength Hope Faith Courage, 1 Seize each New Day with renewed str…
Cancer Is Not A Disease – It’s A Survival MechanismIn Cancer Is Not A Disease, bestselling author and internationally acclaimed health expert, Andreas Moritz, proves the point that …
ParacordsByGeorge – Size 8″ – Rose Pink – Survival Bracelet – 550 paracord…Buy from…ParacordsByGeorge…for the best quality product & service…These bracelets are waterproof, will not rot or mildew,…
Surgery for Lung Cancer (Part 2)
Overview: More than 85 percent of lung cancer cases are smoking-related. In this interview, we hear from a chest surgeon who specializes in treating lung and esophageal cancer about the trends in smoking in the United States. The interview also covers lung cancer, including how it develops and how it is treated. Part One: Cancer death rates Trends in smoking Lung cancer Pack years Second hand smoke Part Two: Diagnosing lung cancer Types of lung cancer Lung cancer symptoms Staging Lobectomy Recurrence Rate Dr. Richard Battafarano, head of thoracic surgery at the University of Maryland Medical Center. Dr. Battafarano is also an associate professor of surgery at the University of Maryland School of Medicine. Links: Lung Cancer Surgery (Part 1) www.youtube.com Lung Cancer Surgery (Part 2) www.youtube.com Maryland Thoracic Surgery www.umm.edu Dr. Richard Battafarano www.umm.edu
Video Rating: 4 / 5
About the Video: Nearly 60000 people in the United States are diagnosed with kidney cancer each year. Viewers of this program will learn about kidney cancer risk factors, symptoms, and some new treatment options that have been developed in recent years. Part one of this two-part program addresses the following topics: Definition of genitourinary cancers Increasing incidence of kidney cancer Types of kidney cancer Risk factors (including smoking) Genetic risks Symptoms Treatment (including chemotherapy, targeted therapies, Interleukin 2 and biological therapies/immunotherapy) Metastatic disease About the Expert: Dr. Arif Hussain is the director of genitourinary oncology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. Dr. Hussain is also a professor of medicine at the University of Maryland School of Medicine. Related Links: Dr. Arif Hussain www.umm.edu Kidney Cancer (Part 2) www.youtube.com University of Maryland Greenebaum Cancer Center www.umgcc.org Genitourinary Oncology Program www.umgcc.org Kidney Cancer FAQ www.umgcc.org Patient Education www.umgcc.org Distributed by Tubemogul.
The Type C Connection: The Behavioral Links to Cancer and Your HealthA look at the connection between specific behavior patterns and cancer argues that the type C personality–someone who is pleasant…
Categories: Cancer Types Tags: Cancer, Lung, part, surgery
Lung cancer impacts 1 in 14 Americans – KABC
It’s a disease that impacts one in 14 Americans, and kills more than breast, prostate, colorectal, leukemia, and melanoma cancers combined. Only 16% of people diagnosed with advanced stage lung cancer survive five years. My mom died from the disease two …
cancer – Bing News
Butterfly Kisses and Wishes on Wings: When someone you love has cancer…a hopeful, helpful book for kidsThis is a listen-to or read-aloud book for children. It is a resource that can be used to educate and support any child who is fa…
Anticancer, A New Way of Life, New EditionThe New York Times and international bestseller-now updated with the latest research Anticancer has been a bestselling phenomen…
One Renegade Cell: How Cancer Begins (Science Masters Series)One of the leading cancer researchers in the world, Robert A. Weinberg is perfectly suited to describe the search for cancer’s ori…
Higher-Dose Radiation Does Not Improve Survival in Some Lung Cancer Patients
A higher dose of radiation therapy does not improve survival in patients with stage III non-small cell lung cancer (NSCLC) who are not candidates for surgery, researchers reported last week. The findings come from an interim analysis of a phase III randomized clinical trial presented at the American Society for Radiation Oncology (ASTRO) annual meeting in Miami.
NCI Cancer Bulletin
Prepackaged (7 3/4 in.) Cancer Awareness Bracelet 18 Colors, 8mmProduct Description
Our Bracelets are Handmade in the USA. Made with 8mm cats eye beads (the red bead here is a glass pearl, not a…
Breast Cancer Pink Ribbon Stickers (Make A Difference design)These We Can Make A Difference pink ribbon stickers are 1.5″ in diameter and have 500 stickers on each roll. Comes in an easy dist…
Categories: Cancer Causes Tags: Cancer, HigherDose, improve, Lung, Patients, Radiation, Some, Survival
Annual screening with chest X-ray does not reduce rate of lung cancer deaths, study finds
In a trial that included more than 150,000 participants, those who underwent annual chest radiographic screening for up to 4 years did not have a significantly lower rate of death from lung cancer compared to participants who were not screened, according to a new study.
ScienceDaily: Cancer News
American Cancer Society Complete Guide to Family Caregiving: The Essential Guide to Cancer Caregiving at HomeUpdated to provide the latest information, techniques, resources, and insights into caregiving, this practical guide offers manage…
Caring for a Loved One with CancerVirtually all of us have a family member or friend who has been diagnosed with cancer. But do we really know how to help? Reflecti…
Card Pack – CaregiverFor those times deserving of more than just a single expression of support, these Card Packs provide support over an extended peri…
Categories: Cancer Caregiver Tags: Annual, Cancer, Chest, deaths, finds, Lung, rate, Reduce, Screening, Study, Xray
Risk Of Rare Lung Cancer Could Be Increased By Goats
According to a study presented at the European Respiratory Society’s Annual Congress in Amsterdam, French researchers discovered that exposure to goats could increase the risk of a certain type of lung cancer, known as pneumonic-type lung adenocarcinoma (P-ADC), which has a weak link to tobacco smoking when compared with other types of the disease…
Cancer / Oncology News From Medical News Today
Foundations in Cancer Research, Volume 65 (Advances in Cancer Research)Foundations in Cancer Research has been a feature of Advances in Cancer Research since Volume 59 in 1992. Foundations chapters pr…
Lung Cancer Research Team Awarded $1.43 Million To Study Cancer In Eastern Kentucky
The University of Kentucky’s Dr. Susanne Arnold and colleagues were awarded a grant by the Department of Defense to study potential environmental reasons for the high lung cancer rates in Eastern Kentucky. The grant is for $ 1.43 million over three years and the study began on Sept. 15…
Cancer / Oncology News From Medical News Today
Foundations in Cancer Research, Volume 65 (Advances in Cancer Research)Foundations in Cancer Research has been a feature of Advances in Cancer Research since Volume 59 in 1992. Foundations chapters pr…
Categories: Cancer Foundation Tags: $1.43, awarded, Cancer, Eastern, Kentucky, Lung, Million, Research, Study, Team
FDA Approves New Drugs to Treat Skin, Blood, and Lung Cancers
In the last 2 weeks of August, the Food and Drug Administration (FDA) approved three new cancer drugs: vemurafenib (Zelboraf), for patients with unresectable or metastatic melanoma whose tumors harbor a specific genetic mutation in the BRAF gene; brentuximab vedotin (Adcetris), for some patients with Hodgkin lymphoma and anaplastic large cell lymphoma; and crizotinib (Xalkori), for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have a gene fusion caused by a chromosomal translocation involving the ALK gene.
NCI Cancer Bulletin
Cancer Cures, Causes And PreventionsAN END TO CANCER STARTING TODAY! THE REAL TRAGEDY OF CANCER IS THAT WE ALREADY HAVE THE CURES! “The doctor of the future will give…
Can Bacteria Cause Cancer?: Alternative Medicine Confronts Big ScienceGrowing numbers of cancer patients are exploring diet, food supplements, herbs, and nontoxic immunotherapies like bacterial vaccin…
Life’s Delicate Balance: Causes and Prevention of Breast CancerWith breast cancer rates soaring, Life’s Delicate Balance defines and documents many causes highlighting means to prevention.Appli…
